NewEdge Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.31M | Buy |
|
|||||
|
2025
Q1 | $5.31M | Sell |
|
|||||
|
2024
Q4 | $5.09M | Buy |
|
|||||
|
2024
Q3 | $5.28M | Sell |
|
|||||
|
2024
Q2 | $6.39M | Buy |
|
|||||
|
2024
Q1 | $5.4M | Buy |
|
|||||
|
2023
Q4 | $4.41M | Buy |
|
|||||
|
2023
Q3 | $3.36M | Buy |
|
|||||
|
2023
Q2 | $3M | Buy |
|
|||||
|
2023
Q1 | $1.76M | Sell |
|
|||||
|
2022
Q4 | $1.47M | Sell |
|
|||||
|
2022
Q3 | $1.75M | Buy |
|
|||||
|
2022
Q2 | $1.32M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $848K | Buy |
|
|||||
|
2021
Q3 | $288K | Sell |
|
|||||
|
2021
Q2 | $381K | Buy |
|
|||||
|
2021
Q1 | $292K | Sell |
|
|||||
|
2020
Q4 | $541K | Sell |
|
|||||
|
2020
Q3 | $4.26M | Buy |
|
|||||
|
2020
Q2 | $954K | Buy |
|
|||||
|
2020
Q1 | $420K | Buy |
|
|||||
|
2019
Q4 | $212K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $235K | Buy |
|
|||||
|
2018
Q4 | $207 | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $14.3K | Buy |
|